Marco Winzer


Marco Winzer


Marco Winzer has been with High-Tech Gründerfonds since its foundation and has helped to establish the fund. The economics graduate has many years of experience in financing start-ups in the life sciences industry and has supported a number of start-ups all along the value chain of the ‘Venture Capital Model’ – from seed financing to successful exit. Before working for HTGF, the Partner acquired expertise in consulting start-ups and held various positions at the Business Innovation Center Kaiserslautern as well as the Technologie-Beteiligungsgesellschaft and development bank KfW.


Posts & mentions

20. October 2022

Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharmato Develop First-in-Class Celiac Disease Therapy

Collaboration Provides Takeda an Exclusive License to Develop and Commercialize ZED1227/TAK-227 in the United States and Other Countries Outside of Europe, Canada, Australia and China Agreement Adds Third Investigational Therapy to Takeda’s Pipeline for the Potential Treatment of Celiac Disease Osaka, Japan, and Freiburg and Darmstadt, Germany, October 20, 2022 – Takeda, Zedira and Dr. Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/T
15. February 2022

Very Successful Exit for High-Tech Gründerfonds - Kerry acquires c-LEcta

This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process developmentThe global presence of Kerry Group plc in the food and pharmaceutical sectors givesc-LEcta access to additional marketsHigh-Tech Gründerfonds was the first seed investor of c-LEcta High-Tech Gründerfonds (“HTGF”) sells its shares in c-LEcta after accompanying the company for 16 years. Kerry Group plc (“Kerry”), the global


25. October 2023
Finance Day Biotech/Life Science
GoingPublic’s published its first Special Edition on Biotechnology in October 1999. Today, 25 years later, we are taking a look back to the future as part of an anniversary event. The aim of the event is to connect the life sciences with knowledge and networks from corporate finance and the capital market. For 25 years. Insights and outlooks on the past, present and future. HTGF partner Marco Winzer participates in the panel “Venture Capital and Financing Trends in Changing TimesR